-
Genomic and transmission dynamics of the 2024 Marburg Virus Outbreak in Rwanda Nat. Med. (IF 58.7) Pub Date : 2024-12-16 Yvan Butera, Leon Mutesa, Edyth Parker, Raissa Muvunyi, Esperance Umumararungu, Alisen Ayitewala, Jean Pierre Musabyimana, Alhaji Olono, Placide Sesonga, Olusola Ogunsanya, Emmanuel Kabalisa, Oluwatobi Adedokun, Nelson Gahima, Laetitia Irankunda, Chantal Mutezemariya, Richard Niyonkuru, Arlene Uwituze, Ithiel Uwizera, James Kagame, Arlette Umugwaneza, John Rwabuhihi, Fidele Umwanankabandi, Valens Mbonitegeka
The ongoing outbreak of Marburg virus disease (MVD) in Rwanda marks the third largest historically, though it has exhibited the lowest fatality rate. Genomic analysis of samples from 18 cases identified a lineage with limited internal diversity, closely related to a 2014 Ugandan case. Our findings suggest that the Rwandan lineage diverged decades ago from a common ancestor shared with diversity sampled
-
Long-acting PrEP prevents HIV in women Nat. Med. (IF 58.7) Pub Date : 2024-12-13 Karen O’Leary
Original reference: N. Engl. J. Med. 391, 1179–1192 (2024)
-
The harms of ultra-processed foods Nat. Med. (IF 58.7) Pub Date : 2024-12-13 Karen O’Leary
Original reference: BMJ 384, e077310 (2024)
-
First tumor-agnostic approval for an ADC Nat. Med. (IF 58.7) Pub Date : 2024-12-13 Karen O’Leary
In April, the HER2-targeting antibody–drug conjugate (ADC) trastuzumab deruxtecan was granted accelerated approval by the US Food and Drug Administration for the treatment of unresectable or metastatic HER2-positive solid tumors. After an initial approval in 2019 for this drug for the treatment of patients with unresectable or metastatic HER2-positive breast cancer, the recent tumor-agnostic approval
-
Multi-organ benefits of incretin agonists Nat. Med. (IF 58.7) Pub Date : 2024-12-13 Karen O’Leary
Following successful clinical trials and approvals for weight loss, accumulating evidence reported this year supports positive effects of incretin agonists — including semagludide (a GLP-1 receptor agonist) and tirzepatide (a dual GLP-1 and GIP receptor agonist) — on cardiovascular and kidney function. The FLOW trial showed that in patients with type 2 diabetes and chronic kidney disease, those treated
-
From clinical to biological definitions of neurological diseases Nat. Med. (IF 58.7) Pub Date : 2024-12-13 Karen O’Leary
February saw the release of revised criteria for the diagnosis and staging of Alzheimer’s disease (AD) by the Alzheimer’s Association Workgroup, to align with recent scientific advances — including the approval of therapies that target AD pathology, and the development of reliable and accessible biomarkers. The new criteria define ‘core’ (specific to AD) and ‘non-core’ biofluid and imaging-based biomarkers;
-
Stem cells reverse type 1 diabetes Nat. Med. (IF 58.7) Pub Date : 2024-12-13 Karen O’Leary
For decades, researchers have tried to harness autologous, pluripotent stem cells to replace lost or damaged tissues in the body — including insulin-producing islet cells — but technical challenges have hampered progress. Finally, in September, a successful first-in-human trial was reported, in which chemically induced pluripotent stem cell-derived islets were transplanted into a single patient with
-
AlphaFold gets an upgrade (and a Nobel) Nat. Med. (IF 58.7) Pub Date : 2024-12-13 Karen O’Leary
AlphaFold, the artificial intelligence tool developed by Google DeepMind to predict protein structure, marked a watershed moment in protein modeling and drug discovery. AlphaFold 2 is able to predict the three-dimensional structure of proteins with very high accuracy — close to that obtained experimentally, which takes months to years. The latest iteration, AlphaFold 3 (released in May), goes a step
-
Health impacts of microplastic exposure Nat. Med. (IF 58.7) Pub Date : 2024-12-13 Karen O’Leary
Microplastics and nanoplastics (MNPs) are everywhere — the oceans, air, soil and food supply — but evidence of their effects on human tissues and organs has been limited mostly to preclinical analyses. In March, a prospective observational study examined carotid plaque specimens from 257 people who underwent a surgical procedure to unblock arteries — and identified MNPs (specifically, polyethylene
-
Prime time for gene editing Nat. Med. (IF 58.7) Pub Date : 2024-12-13 Karen O’Leary
Gene-editing tools are evolving rapidly, from the first CRISPR–Cas systems to base editing and, more recently, prime editing. Unlike CRISPR–Cas systems, base editing does not require double-strand breaks; neither does prime editing, and it supports greater editing power — including targeted insertions and deletions. In April, the US Food and Drug Administration cleared the investigational new drug
-
Exploring patient and public participation in the STANDING Together initiative for AI in healthcare Nat. Med. (IF 58.7) Pub Date : 2024-12-13 Jacqui Gath, Cassandra Leung, Adewale O. Adebajo, Jude Beng, Anmol Arora, Joseph E. Alderman, Joanne Palmer, Elinor Laws, Jaspret Gill, Melissa McCradden, Francis McKay, Alastair Denniston, Xiaoxuan Liu
Public members of STANDING Together reflect on their experience in developing standards to tackle bias in health technologies that use artificial intelligence.
-
Eleven clinical trials that will shape medicine in 2025 Nat. Med. (IF 58.7) Pub Date : 2024-12-12 Paul Webster, Natalie Healey
Nature Medicine asks leading researchers to name their top clinical trial for 2025, from gene therapies for prion disease and sickle-cell disease to digital tools for cancer and mental health.
-
Self-improving generative foundation model for synthetic medical image generation and clinical applications Nat. Med. (IF 58.7) Pub Date : 2024-12-11 Jinzhuo Wang, Kai Wang, Yunfang Yu, Yuxing Lu, Wenchao Xiao, Zhuo Sun, Fei Liu, Zixing Zou, Yuanxu Gao, Lei Yang, Hong-Yu Zhou, Hanpei Miao, Wenting Zhao, Lisha Huang, Lingchao Zeng, Rui Guo, Ieng Chong, Boyu Deng, Linling Cheng, Xiaoniao Chen, Jing Luo, Meng-Hua Zhu, Daniel Baptista-Hon, Olivia Monteiro, Ming Li, Yu Ke, Jiahui Li, Simiao Zeng, Taihua Guan, Jin Zeng, Kanmin Xue, Eric Oermann, Huiyan
-
Identification of distinct types of steatotic liver disease with specific clinical trajectories Nat. Med. (IF 58.7) Pub Date : 2024-12-09
-
Data-driven cluster analysis identifies distinct types of metabolic dysfunction-associated steatotic liver disease Nat. Med. (IF 58.7) Pub Date : 2024-12-09 Violeta Raverdy, Federica Tavaglione, Estelle Chatelain, Guillaume Lassailly, Antonio De Vincentis, Umberto Vespasiani-Gentilucci, Sami F. Qadri, Robert Caiazzo, Helene Verkindt, Chiara Saponaro, Julie Kerr-Conte, Gregory Baud, Camille Marciniak, Mikael Chetboun, Naima Oukhouya-Daoud, Samuel Blanck, Jimmy Vandel, Lisa Olsson, Rima Chakaroun, Viviane Gnemmi, Emmanuelle Leteurtre, Philippe Lefebvre,
-
Partitioned polygenic risk scores identify distinct types of metabolic dysfunction-associated steatotic liver disease Nat. Med. (IF 58.7) Pub Date : 2024-12-09 Oveis Jamialahmadi, Antonio De Vincentis, Federica Tavaglione, Francesco Malvestiti, Ruifang Li-Gao, Rosellina M. Mancina, Marcus Alvarez, Kyla Gelev, Samantha Maurotti, Umberto Vespasiani-Gentilucci, Frits Richard Rosendaal, Julia Kozlitina, Päivi Pajukanta, François Pattou, Luca Valenti, Stefano Romeo
-
Publisher Correction: Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b/4 trial Nat. Med. (IF 58.7) Pub Date : 2024-12-09 Nadia Harbeck, Eva Ciruelos, Guy Jerusalem, Volkmar Müller, Naoki Niikura, Giuseppe Viale, Rupert Bartsch, Christian Kurzeder, Michaela J. Higgins, Roisin M. Connolly, Sally Baron-Hay, María Gión, Valentina Guarneri, Giampaolo Bianchini, Hans Wildiers, Santiago Escrivá-de-Romaní, Manoj Prahladan, Helen Bridge, Nataliya Kuptsova-Clarkson, Nana Scotto, Sunil Verma, Nancy U. Lin
Correction to: Nature Medicine https://doi.org/10.1038/s41591-024-03261-7, published online 13 September 2024.
-
Vascular cells of blood vessels and organs across the human body Nat. Med. (IF 58.7) Pub Date : 2024-12-06
-
Seven unanswered questions about blockbuster weight-loss drugs Nat. Med. (IF 58.7) Pub Date : 2024-12-04 Mike May
-
How big data can improve women’s health Nat. Med. (IF 58.7) Pub Date : 2024-12-03 Anita Zaidi
Health data should measure the complexity of women’s lives.
-
Hypothalamic deep brain stimulation augments walking after spinal cord injury Nat. Med. (IF 58.7) Pub Date : 2024-12-02 Newton Cho, Jordan W. Squair, Viviana Aureli, Nicholas D. James, Léa Bole-Feysot, Inssia Dewany, Nicolas Hankov, Laetitia Baud, Anna Leonhartsberger, Kristina Sveistyte, Michael A. Skinnider, Matthieu Gautier, Achilleas Laskaratos, Katia Galan, Maged Goubran, Jimmy Ravier, Frederic Merlos, Laura Batti, Stéphane Pages, Nadia Berard, Nadine Intering, Camille Varescon, Anne Watrin, Léa Duguet, Stefano
-
Declaration of Helsinki embraces health equity Nat. Med. (IF 58.7) Pub Date : 2024-12-02
The updated Declaration of Helsinki empowers ethics committees to require community engagement and equitable partnerships
-
Early readout shows promise of genomic newborn screening Nat. Med. (IF 58.7) Pub Date : 2024-11-27
Interim results from a large, ongoing study shows that genomic newborn screening identifies treatable conditions that would be missed by standard tests.
-
Lifestyle interventions for cardiometabolic health Nat. Med. (IF 58.7) Pub Date : 2024-11-27 Femke Rutters, Nicolette R. den Braver, Jeroen Lakerveld, Joreintje D. Mackenbach, Hidde P. van der Ploeg, Simon Griffin, Petra J. M. Elders, Joline W. J. Beulens
-
Internet use linked to better mental health in older adults Nat. Med. (IF 58.7) Pub Date : 2024-11-26
According to a large international study, Internet use among adults 50 or more years of age correlates with reduced depressive symptoms, increased life satisfaction and improved self-reported health.
-
Genetic basis of early onset and progression of type 2 diabetes in South Asians Nat. Med. (IF 58.7) Pub Date : 2024-11-26 Sam Hodgson, Alice Williamson, Margherita Bigossi, Daniel Stow, Benjamin M. Jacobs, Miriam Samuel, Joseph Gafton, Julia Zöllner, Marie Spreckley, Claudia Langenberg, David A. van Heel, Rohini Mathur, Moneeza K. Siddiqui, Sarah Finer
-
Cognitive deficits after COVID-19 associated with brain injury biomarkers and volume loss Nat. Med. (IF 58.7) Pub Date : 2024-11-25
-
Using tumor DNA methylomes to predict cancer metastasis to the brain Nat. Med. (IF 58.7) Pub Date : 2024-11-22
-
Obesity predisposes to specific cancer driver mutations Nat. Med. (IF 58.7) Pub Date : 2024-11-22
A large-scale genomic analysis reveals associations between body mass index and certain driver mutations in various cancer types, particularly lung adenocarcinoma.
-
Citizen science as an instrument for women’s health research Nat. Med. (IF 58.7) Pub Date : 2024-11-22 Sarah Ahannach, Ine Van Hoyweghen, Veronique Verhoeven, Sarah Lebeer
-
High-resolution spatial multiomic census of the human placenta Nat. Med. (IF 58.7) Pub Date : 2024-11-20
-
An organotypic atlas of human vascular cells Nat. Med. (IF 58.7) Pub Date : 2024-11-20 Sam N. Barnett, Ana-Maria Cujba, Lu Yang, Ana Raquel Maceiras, Shuang Li, Veronika Kedlian, J. Patrick Pett, Krzysztof Polanski, Antonio M. A. Miranda, Chuan Xu, James Cranley, Kazumasa Kanemaru, Michael Lee, Lukas Mach, Shani Perera, Catherine Tudor, Philomeena D. Joseph, Sophie Pritchard, Rebecca Toscano-Rivalta, Kelvin Tuong, Liam Bolt, Robert Petryszak, Martin Prete, Batuhan Cakir, Alik Huseynov
The human vascular system, comprising endothelial (EC) and mural cells, covers a vast surface area in the body, providing a critical interface between blood and tissue environments. Functional differences exist across specific vascular beds, but their molecular determinants across tissues remain largely unknown. Here, we integrated single-cell transcriptomics data from 19 human organs and tissues,
-
Spatial multiomic landscape of the human placenta at molecular resolution Nat. Med. (IF 58.7) Pub Date : 2024-11-20 Johain R. Ounadjela, Ke Zhang, Koseki J. Kobayashi-Kirschvink, Kang Jin, Andrew J. C. Russell, Andreas I. Lackner, Claire Callahan, Francesca Viggiani, Kushal K. Dey, Karthik Jagadeesh, Theresa Maxian, Anna-Maria Prandstetter, Naeem Nadaf, Qiyu Gong, Ruth Raichur, Morgan L. Zvezdov, Mingyang Hui, Mattew Simpson, Xinwen Liu, Wei Min, Martin Knöfler, Fei Chen, Sandra Haider, Jian Shu
-
Spatially resolved single-cell atlas unveils a distinct cellular signature of fatal lung COVID-19 in a Malawian population Nat. Med. (IF 58.7) Pub Date : 2024-11-20 James Nyirenda, Olympia M. Hardy, João Da Silva Filho, Vanessa Herder, Charalampos Attipa, Charles Ndovi, Memory Siwombo, Takondwa Rex Namalima, Leticia Suwedi, Georgios Ilia, Watipenge Nyasulu, Thokozile Ngulube, Deborah Nyirenda, Leonard Mvaya, Joseph Phiri, Dennis Chasweka, Chisomo Eneya, Chikondi Makwinja, Chisomo Phiri, Frank Ziwoya, Abel Tembo, Kingsley Makwangwala, Stanley Khoswe, Peter Banda
-
Author Correction: Subclassification of obesity for precision prediction of cardiometabolic diseases Nat. Med. (IF 58.7) Pub Date : 2024-11-21 Daniel E. Coral, Femke Smit, Ali Farzaneh, Alexander Gieswinkel, Juan Fernandez Tajes, Thomas Sparsø, Carl Delfin, Pierre Bauvin, Kan Wang, Marinella Temprosa, Diederik De Cock, Jordi Blanch, José Manuel Fernández-Real, Rafael Ramos, M. Kamran Ikram, Maria F. Gomez, Maryam Kavousi, Marina Panova-Noeva, Philipp S. Wild, Carla van der Kallen, Michiel Adriaens, Marleen van Greevenbroek, Ilja Arts, Carel
Correction to: Nature Medicine https://doi.org/10.1038/s41591-024-03299-7, published online 24 October 2024.
-
Limiting babies’ sugar intake protects them against chronic diseases Nat. Med. (IF 58.7) Pub Date : 2024-11-20
Post-war rationing in the UK in 1953 facilitated a natural experiment that now reveals that restricting sugar intake in early life reduces the risk of diabetes and hypertension.
-
Editorial Expression of Concern: Tumor-selective action of HDAC inhibitors involves TRAIL induction in acute myeloid leukemia cells Nat. Med. (IF 58.7) Pub Date : 2024-11-20 Angela Nebbioso, Nicole Clarke, Emilie Voltz, Emmanuelle Germain, Concetta Ambrosino, Paola Bontempo, Rosana Alvarez, Ettore M. Schiavone, Felicetto Ferrara, Francesco Bresciani, Alessandro Weisz, Angel R. de Lera, Hinrich Gronemeyer, Lucia Altucci
Addendum to: Nature Medicine https://doi.org/10.1038/nm1161, published online 26 December 2004.
-
Effects of tirzepatide on circulatory overload and end-organ damage in heart failure with preserved ejection fraction and obesity: a secondary analysis of the SUMMIT trial Nat. Med. (IF 58.7) Pub Date : 2024-11-17 Barry A. Borlaug, Michael R. Zile, Christopher M. Kramer, Seth J. Baum, Karla Hurt, Sheldon E. Litwin, Masahiro Murakami, Yang Ou, Navneet Upadhyay, Milton Packer
-
Author Correction: Duvelisib plus romidepsin in relapsed/refractory T cell lymphomas: a phase 1b/2a trial Nat. Med. (IF 58.7) Pub Date : 2024-11-15 Steven M. Horwitz, Ajit J. Nirmal, Jahan Rahman, Ran Xu, Esther Drill, Natasha Galasso, Nivetha Ganesan, Theresa Davey, Helen Hancock, Leslie Perez, Catherine Maccaro, Alexandra Bahgat, Evan Marzouk, Elizabeth Cathcart, Alison Moskowitz, Ariela Noy, Anita Kumar, Eric Jacobsen, David C. Fisher, Neha Mehta-Shah, Youn H. Kim, Michael Khodadoust, Nikita Kotlov, Anastasia Nikitina, Olga Kudryashova, Valeria
Correction to: Nature Medicine https://doi.org/10.1038/s41591-024-03076-6, published online 17 June 2024.
-
Are GLP-1 drugs really for everybody? Nat. Med. (IF 58.7) Pub Date : 2024-11-14
As GLP-1 receptor agonists emerge as treatment options for conditions beyond diabetes and obesity, it becomes critical to understand how genetic, clinical and sociodemographic differences impact their effects on weight loss.
-
Lipid signatures of cardiometabolic risk in children and adolescents with obesity Nat. Med. (IF 58.7) Pub Date : 2024-11-14
-
Seven-year performance of a clinical metagenomic next-generation sequencing test for diagnosis of central nervous system infections Nat. Med. (IF 58.7) Pub Date : 2024-11-12 Patrick Benoit, Noah Brazer, Mikael de Lorenzi-Tognon, Emily Kelly, Venice Servellita, Miriam Oseguera, Jenny Nguyen, Jack Tang, Charles Omura, Jessica Streithorst, Melissa Hillberg, Danielle Ingebrigtsen, Kelsey Zorn, Michael R. Wilson, Tim Blicharz, Amy P. Wong, Brian O’Donovan, Brad Murray, Steve Miller, Charles Y. Chiu
-
Moving toward response-adapted trials in oncology Nat. Med. (IF 58.7) Pub Date : 2024-11-11 Jose Pérez-García, Gabriele Antonarelli, Maria Gion, Antonio Llombart-Cussac, Javier Cortés
-
H5N1 from an infected dairy worker sheds light on viral transmission Nat. Med. (IF 58.7) Pub Date : 2024-11-11
Two studies reveal high transmissibility and lethality of the viral isolate in animal models, and hint at potential drug susceptibility — but further analysis and ongoing surveillance of infections will be critical for public health.
-
TRBC1-CAR T cell therapy in peripheral T cell lymphoma: a phase 1/2 trial Nat. Med. (IF 58.7) Pub Date : 2024-11-11 Kate Cwynarski, Gloria Iacoboni, Eleni Tholouli, Tobias Menne, David A. Irvine, Nivetha Balasubramaniam, Leigh Wood, Justin Shang, Eric Xue, Yiyun Zhang, Silvia Basilico, Margarida Neves, Meera Raymond, Ian Scott, Mohamed El-Kholy, Ram Jha, Heather Dainton-Smith, Rehan Hussain, William Day, Mathieu Ferrari, Simon Thomas, Koki Lilova, Wolfram Brugger, Teresa Marafioti, Pierre Lao-Sirieix, Paul Maciocia
-
Oncolytic immunotherapy with nivolumab in muscle-invasive bladder cancer: a phase 1b trial Nat. Med. (IF 58.7) Pub Date : 2024-11-09 Roger Li, Nancy Y. Villa, Xiaoqing Yu, Joseph O. Johnson, Gustavo Borjas, Jasreman Dhillon, Carlos M. Moran-Segura, Youngchul Kim, Natasha Francis, Denise Dorman, John J. Powers, Wade J. Sexton, Philippe E. Spiess, Michael A. Poch, Logan Zemp, Scott M. Gilbert, Jingsong Zhang, Julio M. Pow-Sang, Alexander R. A. Anderson, Tingyi Li, Xuefeng Wang, G. Daniel Grass, James M. Burke, Colin P. N. Dinney,
-
Collaboration between clinicians and vision–language models in radiology report generation Nat. Med. (IF 58.7) Pub Date : 2024-11-07 Ryutaro Tanno, David G. T. Barrett, Andrew Sellergren, Sumedh Ghaisas, Sumanth Dathathri, Abigail See, Johannes Welbl, Charles Lau, Tao Tu, Shekoofeh Azizi, Karan Singhal, Mike Schaekermann, Rhys May, Roy Lee, SiWai Man, Sara Mahdavi, Zahra Ahmed, Yossi Matias, Joelle Barral, S. M. Ali Eslami, Danielle Belgrave, Yun Liu, Sreenivasa Raju Kalidindi, Shravya Shetty, Vivek Natarajan, Pushmeet Kohli, Po-Sen
-
HIV-1 remission following stem cell transplant without CCR5Δ32 mutation Nat. Med. (IF 58.7) Pub Date : 2024-11-06
-
A systematic review and meta-analysis of heat exposure impacts on maternal, fetal and neonatal health Nat. Med. (IF 58.7) Pub Date : 2024-11-05 Darshnika P. Lakhoo, Nicholas Brink, Lebohang Radebe, Marlies H. Craig, Minh Duc Pham, Marjan M. Haghighi, Amy Wise, Ijeoma Solarin, Stanley Luchters, Gloria Maimela, Matthew F. Chersich
Climate Change has severe and wide-ranging health impacts, especially for vulnerable groups. Despite growing evidence of heat-associated adverse maternal and neonatal health outcomes, there remains a lack of synthesis quantifying associations and identifying specific risk periods. We systematically reviewed the literature on heat impacts on maternal, fetal, and neonatal health, and quantified impacts
-
Clinical validation of an AI-based pathology tool for scoring of metabolic dysfunction-associated steatohepatitis Nat. Med. (IF 58.7) Pub Date : 2024-11-04 Hanna Pulaski, Stephen A. Harrison, Shraddha S. Mehta, Arun J. Sanyal, Marlena C. Vitali, Laryssa C. Manigat, Hypatia Hou, Susan P. Madasu Christudoss, Sara M. Hoffman, Adam Stanford-Moore, Robert Egger, Jonathan Glickman, Murray Resnick, Neel Patel, Cristin E. Taylor, Robert P. Myers, Chuhan Chung, Scott D. Patterson, Anne-Sophie Sejling, Anne Minnich, Vipul Baxi, G. Mani Subramaniam, Quentin M. Anstee
-
Exploring the limits of life extension Nat. Med. (IF 58.7) Pub Date : 2024-10-31
The twentieth century saw unprecedented rises in life expectancy in high-income countries, but data suggest that this trend will not continue in the current century without radical interventions to slow biological aging.
-
Culturally adapted CBT for postnatal depression Nat. Med. (IF 58.7) Pub Date : 2024-10-31
In British South Asian women, a culturally adapted and community-informed cognitive behavioral therapy intervention led to higher early recovery rates than the usual treatment.
-
Mapping metastatic breast cancer complexity through single-cell and spatial profiling Nat. Med. (IF 58.7) Pub Date : 2024-10-30
-
A multi-modal single-cell and spatial expression map of metastatic breast cancer biopsies across clinicopathological features Nat. Med. (IF 58.7) Pub Date : 2024-10-30 Johanna Klughammer, Daniel L. Abravanel, Åsa Segerstolpe, Timothy R. Blosser, Yury Goltsev, Yi Cui, Daniel R. Goodwin, Anubhav Sinha, Orr Ashenberg, Michal Slyper, Sébastien Vigneau, Judit Jané‐Valbuena, Shahar Alon, Chiara Caraccio, Judy Chen, Ofir Cohen, Nicole Cullen, Laura K. DelloStritto, Danielle Dionne, Janet Files, Allison Frangieh, Karla Helvie, Melissa E. Hughes, Stephanie Inga, Abhay Kanodia
-
Regulatory reforms will boost African vaccine production and access Nat. Med. (IF 58.7) Pub Date : 2024-10-29 Niteen Wairagkar, Alex Juma Ismail, Dalia M. N. Abouhussein, Moji Christianah Adeyeye, Delese Mimi Darko, Adam Mitangu Fimbo, Richard T. Rukwata, Boitumelo (Tumi) Semete-Makokotlela, Michele Sidibe, Nicaise Ndembi
-
Recommendations to promote equity, diversity and inclusion in decentralized clinical trials Nat. Med. (IF 58.7) Pub Date : 2024-10-29 Olalekan Lee Aiyegbusi, Samantha Cruz Rivera, Paul Kamudoni, Nicola Anderson, Philip Collis, Alastair K. Denniston, Rosie Harding, Sarah E. Hughes, Kamlesh Khunti, Dipak Kotecha, Harlan Krumholz, Xiaoxuan Liu, Christel McMullan, Barbara Molony-Oates, Joao Monteiro, Puja Myles, Khadija Rerhou Rantell, Katherine Soltys, Ravinder Verdi, Roger Wilson, Melanie J. Calvert
-
Using AVATAR therapy to conquer auditory hallucinations Nat. Med. (IF 58.7) Pub Date : 2024-10-28 Merete Nordentoft
-
Digital AVATAR therapy for distressing voices in psychosis: the phase 2/3 AVATAR2 trial Nat. Med. (IF 58.7) Pub Date : 2024-10-28 Philippa A. Garety, Clementine J. Edwards, Hassan Jafari, Richard Emsley, Mark Huckvale, Mar Rus-Calafell, Miriam Fornells-Ambrojo, Andrew Gumley, Gillian Haddock, Sandra Bucci, Hamish J. McLeod, Jeffrey McDonnell, Moya Clancy, Michael Fitzsimmons, Hannah Ball, Alice Montague, Nikos Xanidis, Amy Hardy, Thomas K. J. Craig, Thomas Ward
-
Author Correction: Finerenone in heart failure and chronic kidney disease with type 2 diabetes: FINE-HEART pooled analysis of cardiovascular, kidney and mortality outcomes Nat. Med. (IF 58.7) Pub Date : 2024-10-28 Muthiah Vaduganathan, Gerasimos Filippatos, Brian L. Claggett, Akshay S. Desai, Pardeep S. Jhund, Alasdair Henderson, Meike Brinker, Peter Kolkhof, Patrick Schloemer, James Lay-Flurrie, Prabhakar Viswanathan, Carolyn S. P. Lam, Michele Senni, Sanjiv J. Shah, Adriaan A. Voors, Faiez Zannad, Peter Rossing, Luis M. Ruilope, Stefan D. Anker, Bertram Pitt, Rajiv Agarwal, John J. V. McMurray, Scott D. Solomon
Correction to: Nature Medicine https://doi.org/10.1038/s41591-024-03264-4, published online 1 September 2024.
-
Unprecedented spread and genetic evolution of the Oropouche virus Nat. Med. (IF 58.7) Pub Date : 2024-10-28 Marcia C. Castro, Antônio Silva Lima Neto
The current Oropouche fever outbreak has been traced to a novel reassortant virus that emerged about a decade ago, which highlights the importance of One Health surveillance in preventing, predicting, detecting and responding to emerging threats.